Condition
We Focus on the Pain of Venipuncture and Intravenous Cannulation
Total Trials
1
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Lidocaine
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 2/3 (1)
Trial Status
Unknown1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Lidocaine1
Active Sponsors
- RenJi Hospital1
- Giant Med-Pharma Services Inc.1
- Nitto Denko Corporation1
Top Investigators
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Renji Hospital, School of Medicine, Shanghai Jiaotong University